Publications by authors named "C P Klimko"

In the United States in 2021, an outbreak of 4 cases of Burkholderia pseudomallei, the etiologic agent of melioidosis and a Tier One Select Agent (potential for deliberate misuse and subsequent harm), resulted in 2 deaths. The causative strain, B. pseudomallei ATS2021, was unintentionally imported into the United States in an aromatherapy spray manufactured in India.

View Article and Find Full Text PDF

Yersinia pestis, the causative agent of plague and a biological threat agent, presents an urgent need for novel medical countermeasures due to documented cases of naturally acquired antibiotic resistance and potential person-to-person spread during a pneumonic infection. Immunotherapy has been proposed as a way to circumvent current and future antibiotic resistance. Here, we describe the development and characterization of two affinity matured human antibodies (αF1Ig AM2 and αF1Ig AM8) that promote survival of mice after exposure to aerosolized Y.

View Article and Find Full Text PDF
Article Synopsis
  • Plague is caused by a bacterium and can show up as different types of disease; antibiotics are essential for treatment, but there's no FDA-approved vaccine yet, and some candidates may work better for certain forms of the disease.
  • The study tested new vaccine approaches on male and female mice and found that the best regimen involved an initial vaccination followed by a boost, with notable differences in effectiveness between sexes.
  • Results showed that female mice had better protection and immune responses compared to males, who also showed higher bacterial loads and different immune reactions, highlighting the importance of understanding sex differences in vaccine development.
View Article and Find Full Text PDF

is one of the several biothreat agents for which a licensed vaccine is needed. To ensure vaccine protection is achieved across a range of virulent strains, we assembled and characterized a panel of isolates to be utilized as challenge strains. A promising tularemia vaccine candidate is rLVS Δ/ (rLVS), in which the vector is the LVS strain with a deletion in the gene and which additionally expresses a fusion protein comprising immunodominant epitopes of proteins IglA, IglB, and IglC.

View Article and Find Full Text PDF

is a gram-negative bacterium that causes plague in animals and humans. Depending on the route of disease transmission, the bacterium can cause an acute, often fatal disease that has a narrow window for treatment with antibiotics. Additionally, antibiotic resistant strains have been identified, emphasizing the need for novel treatments.

View Article and Find Full Text PDF